The microbiota-mediated dietary and nutritional interventions for COVID-19
- PMID: 33845194
- PMCID: PMC8032598
- DOI: 10.1016/j.clim.2021.108725
The microbiota-mediated dietary and nutritional interventions for COVID-19
Abstract
Worldwide, scientists are looking for specific treatment for COVID-19. Apart from the antiviral approach, the interventions to support healthy immune responses to the virus are feasible through diet, nutrition, and lifestyle approaches. This narrative review explores the recent studies on dietary, nutritional, and lifestyle interventions that influence the microbiota-mediated immunomodulatory effects against viral infections. Cumulative studies reported that the airway microbiota and SARS-CoV-2 leverage each other and determine the pathogen-microbiota-host responses. Cigarette smoking can disrupt microbiota abundance. The composition and diversification of intestinal microbiota influence the airway microbiota and the innate and adaptive immunity, which require supports from the balance of macro- and micronutrients from the diet. Colorful vegetables supplied fermentable prebiotics and anti-inflammatory, antioxidant phytonutrients. Fermented foods and beverages support intestinal microbiota. In sensitive individuals, the avoidance of the high immunoreactive food antigens contributes to antiviral immunity. This review suggests associations between airway and intestinal microbiota, antiviral host immunity, and the influences of dietary, nutritional, and lifestyle interventions to prevent the clinical course toward severe COVID-19.
Keywords: COVID-19; Gut-lung axis; Microbiota; Prebiotics; Probiotics; SARS-CoV-2.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare they have no actual or potential competing financial interests.
Figures

Similar articles
-
Gut Microbiota and COVID-19: Unraveling the Gut-Lung Axis and Immunomodulatory Therapies.ACS Infect Dis. 2025 Jul 11;11(7):1844-1853. doi: 10.1021/acsinfecdis.5c00250. Epub 2025 Jun 5. ACS Infect Dis. 2025. PMID: 40471123 Free PMC article. Review.
-
[Fermented milk and probiotic foods are an important part of population diet during SARS-CoV-2 pandemic].Vopr Pitan. 2022;91(1):86-97. doi: 10.33029/0042-8833-2022-91-1-86-97. Epub 2022 Jan 11. Vopr Pitan. 2022. PMID: 35298107 Review. Russian.
-
Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.Recent Pat Biotechnol. 2021 Oct 4;15(2):112-136. doi: 10.2174/1872208315666210419103742. Recent Pat Biotechnol. 2021. PMID: 33874878 Review.
-
From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.Mediators Inflamm. 2021 Apr 16;2021:6611222. doi: 10.1155/2021/6611222. eCollection 2021. Mediators Inflamm. 2021. PMID: 33953641 Free PMC article. Review.
-
Intestinal Microbiota-A Promising Target for Antiviral Therapy?Front Immunol. 2021 May 12;12:676232. doi: 10.3389/fimmu.2021.676232. eCollection 2021. Front Immunol. 2021. PMID: 34054866 Free PMC article. Review.
Cited by
-
Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?Foods. 2022 Sep 17;11(18):2884. doi: 10.3390/foods11182884. Foods. 2022. PMID: 36141012 Free PMC article. Review.
-
Role of the Microbiome in the Pathogenesis of COVID-19.Front Cell Infect Microbiol. 2022 Mar 31;12:736397. doi: 10.3389/fcimb.2022.736397. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35433495 Free PMC article. Review.
-
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy.Int J Mol Sci. 2023 Jul 31;24(15):12249. doi: 10.3390/ijms241512249. Int J Mol Sci. 2023. PMID: 37569625 Free PMC article. Review.
-
Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications.J Food Biochem. 2022 Dec;46(12):e14445. doi: 10.1111/jfbc.14445. Epub 2022 Oct 14. J Food Biochem. 2022. PMID: 36239436 Free PMC article. Review.
-
Major alteration of Lung Microbiome and the Host Reaction in critically ill COVID-19 Patients with high viral load.Res Sq [Preprint]. 2024 Mar 8:rs.3.rs-3952944. doi: 10.21203/rs.3.rs-3952944/v1. Res Sq. 2024. Update in: Sci Rep. 2024 Nov 12;14(1):27637. doi: 10.1038/s41598-024-78992-1. PMID: 38496464 Free PMC article. Updated. Preprint.
References
-
- World Health Organization . 2020. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) p. 40.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous